Browse Legislation

SB 915 - This act establishes the "Delivery Network Company Insurance Act". This act provides that a delivery network company (DNC) shall ensure that, during the delivery availability period and delivery service period, as such terms are defined in the act, primary motor vehicle insurance is in effect that recognizes that the operator of the motor vehicle is a DNC driver or does not exclude coverage for use of a personal vehicle to provide deliveries. During the delivery service period and delivery availability period, the DNC driver or company, or a combination of the two, shall maintain motor vehicle liability insurance coverage that insures the driver for liability to third parties of not less than $50,000 for damages arising out of bodily injury sustained by one person, $100,000 for damages arising out of bodily injury sustained by all persons, and $25,000 for all damages arising out of damage to or destruction of property in an accident. If the insurance required by this act has lapsed or does not provide adequate coverage, the insurance coverage maintained by the DNC shall provide such coverage beginning with the first dollar of a claim, and shall provided that the insurer has the duty to defend the claim. In the event of an accident, a DNC driver shall provide insurance coverage information directly to interested parties, insurers, and investigating law enforcement officers, and shall disclose to such persons whether the DNC driver was operating during the delivery availability period or delivery service period at the time of the accident. An insurer providing coverage required by the act shall assume primary liability for a claim when a dispute exists as to when the delivery availability period or delivery service period began or ended, and when the DNC does not have available, did not retain, or fails to provide information required by the act. A DNC shall not be deemed to control, direct, or manage a personal vehicle or DNC driver who connects to the DNC's digital network unless agreed to by written contract. An insurer may exclude coverage and deny the duty to defend or indemnify for a claim of injury or loss that occurs during the delivery availability period and delivery service period. This act shall become effective on October 1, 2027. This act is substantially similar to HB 1789 (2026). TAYLOR MIDDLETON

SB 1587 - Currently, Franklin County, located in the 20th Judicial District, has three associate circuit judges per the statutory formula. This act provides for an additional associate circuit judge for Franklin County to be appointed by the Governor until January 1, 2029, and elected thereafter. This act is identical to a provision in SCS/HB 1625 (2026) and is substantially similar to a provision in HCS/SB 945 (2026), in HCS/SB 1067 (2206), HB 2386 (2026), and in HCS/HBs 2968, 2427 & 3086 (2026). KATIE O'BRIEN

SB 1677 - This act modifies provisions relating to child passengers on motorcycles and motortricycles. SAFETY REQUIREMENTS AND PENALTY PROVISIONS (Sections 302.020.2 to 302.020.3) No person shall be stopped, inspected, or detained solely to determine that the protective headgear worn by an operator or passenger of a motorcycle or motortricycle meets reasonable standards and specifications, unless there is a reasonable basis to suspect that a violation of this act involves a child passenger under ten years of age. The penalty for failure to wear protective headgear as required by this act is an infraction for which a fine not to exceed twenty-five dollars may be imposed unless the violation involves a child passenger under ten years of age, in which case the violation shall be punishable as an infraction for which a fine not to exceed one hundred dollars may be imposed. CALVIN'S LAW (Section 302.023) This act establishes "Calvin's Law". It shall be unlawful for the operator of a motorcycle or motortricycle to allow any person under ten years of age to ride as a passenger on a motorcycle or motortricycle on any highway in this state unless the motorcycle or motortricycle is equipped with a proper passenger seat and the child is able to place both feet on the passenger foot pegs, except when a licensed physician certifies a medical exemption. Any passenger under ten years of age shall wear protective headgear that meets the safety standards and specifications established by the director of revenue. This act shall be effective on January 1, 2027. This act is identical to HCS/HBs 2553, 1831, & 2328 (2026), HB 2328 (2026), and HB 3085 (2026), HB 1831 (2026). TAYLOR MIDDLETON

SB 1462 - This act provides that vehicle identification number and odometer inspections for titling purposes may be performed by an employee of a licensed new or used motor vehicle dealer if the vehicle is sold to a person who lives out of state and intends to register the vehicle out of state, or if the motor vehicle has less than 30,000 miles for the three-year period following the model year of manufacture. The act also exempts these vehicles from safety and emissions inspections prior to sale if the vehicle is sold by a private seller or by a licensed motor vehicle dealer that has sold at least 200 motor vehicles in the previous calendar year. The act further modifies the requirement to perform a safety inspection prior to sale to specify that a pre-sale inspection shall be performed no more than 60 days prior to sale, rather than "immediately prior to sale". This act contains provisions similar to HB 3041 (2026), HB 2655 (2026), is similar to SB 645 (2025), HB 1018 (2025), and HCS/HB 2317 (2024). TAYLOR MIDDLETON

Modifies provisions relating to tax credits

SB 1217 - Current law requires an excuse in order to vote absentee beginning the 6th Tuesday prior to the election. This act repeals the need for an excuse and instead allows voting absentee with no excuse beginning on the 6th Tuesday prior to the election. This act is identical to SB 470 (2025) and substantially similar to HB 1883 (2024). SCOTT SVAGERA

SB 1296 - Current law authorizes state agencies to set off all or a portion of a taxpayer's income tax refund to repay debts owed to such state agency. This act modifies the definition of "state agency" to include any municipality with a population over 250,000 for debts arising on or after January 1, 2027. This act is identical to SB 468 (2025) and HB 1884 (2024). JOSH NORBERG

SB 852 - This act provides that, for all automobile insurance contracts entered into on or after August 28, 2026, no insurer shall utilize any information obtained directly or indirectly from a consumer reporting agency or any insurance credit score that relies on information obtained directly or indirectly from a consumer reporting agency for the purpose of determining the rate charged for such contract. This act is identical to HB 2632 (2026). TAYLOR MIDDLETON

SB 1156 - This act prohibits health benefit plans from imposing cost-sharing, as defined in the act, on an enrollee in excess of thirty dollars per thirty-day supply of a prescription insulin drug. This act also requires health benefit plan enrollees' cost-sharing for prescription insulin drugs to be calculated at the point of sale, and based on a price that is reduced by an amount equal to at least 100% of all rebates received, or to be received, in connection with the dispensing or administration of the drug. Nothing in the act shall prohibit copayments not based on the price of a drug, provided that the copayment does not exceed the reduced price of the drug. The act shall not require a health carrier or its agents to reveal information regarding the actual amount of rebates a carrier receives on a product, manufacturer, or pharmacy-specific basis. The act also provides confidentiality protections, as specified in the act, which the carriers shall follow as well as impose on any third party that performs health care or administrative services on behalf of the carrier and may receive or have access to rebate information. This act applies to health benefit plans delivered, issued, continued, or renewed in the state on or after January 1, 2027. This act is identical to HB 3117 (2026), SB 175 (2025), similar to provisions in HCS/HB 1195 (2025) and HB 186 (2025), identical to HB 2262 (2024), substantially similar to SB 1182 (2024), identical to SB 283 (2023), similar to SB 815 (2022), and contains provisions similar to SB 814 (2022). TAYLOR MIDDLETON

SB 1089 - This act provides that health benefit plans providing for maternity benefits shall provide coverage for a home blood pressure monitoring device and home blood pressure monitoring device services, as defined in the act, for pregnant and postpartum women. This act contains provisions identical to provisions in SB 539 (2025), substantially similar to provisions in HCS/HB 2371 (2026), HB 842 (2025), and similar to provisions in the truly agreed to and finally passed SS/SCS/HCS/HB 2372 (2026), the truly agreed to and finally passed HCS/SS/SCS/SB 878 (2026), and SB 498 (2025). TAYLOR MIDDLETON

SB 929 - Under this act, current law requiring certain health benefit plans to provide coverage for contraceptives lasting up to 90 days, or 180 days for generic self-administered hormonal contraceptives, shall no longer be in effect after December 31, 2026. Instead, certain health benefit plans issued or renewed on or after January 1, 2027, shall be required to cover a supply of self-administered hormonal contraceptives, including brand-name and generic contraceptives, intended to last up to one year. This act is substantially similar to provisions in the truly agreed to and finally passed SS/SCS/HCS/HB 2372 (2026), the truly agreed to and finally passed CCS/SS/HCS/HB 2596 (2026), and HB 2370 (2026), and similar to a provision in SCS/SB 178 (2025), HCS/SS/SB 7 (2025), HCS/SB 94 (2025), the perfected HCS/HB 2413 (2024), SB 821 (2024), and SB 1321 (2024). TAYLOR MIDDLETON

SB 1340 - Under this act, a health carrier, a pharmacy benefits manager, or an agent or affiliate of such, shall not discriminate against a covered entity, as defined in the act, including by reimbursing the covered entity for a quantity of a 340B drug in an amount less than it would pay similarly situated non-covered entities for such drugs, imposing different terms and conditions as compared to similarly situated entities, refusing to cover 340B drugs or discriminating in reimbursement for 340B drugs, and other situations described under this act. The Director of the Department of Commerce and Insurance shall impose a civil penalty on any health carrier, pharmacy benefits manager, or agent or affiliate of such, that violates this provision, not to exceed $5,000 per violation per day. This act is identical to HCS/SB 1019, provisions in the truly agreed to and finally passed 878 (2026), SB 841 (2026), provisions in the truly agreed to and finally passed SS/SCS/HCS/HB 2372 (2026), and SCS/HB 2146 (2026), and similar to a provision in SCS/HCS/HB 943 (2025) and HB 784 (2025). TAYLOR MIDDLETON

SB 1448 - This act provides that when calculating an enrollee's overall contribution to an out-of-pocket max or any cost-sharing requirement under a health benefit plan, a health carrier or pharmacy benefits manager shall include any amounts paid by the enrollee or paid on behalf of the enrollee for any medication for which a generic substitute is not available. Additionally, no health carrier or pharmacy benefits manager shall design benefits in a manner that takes into account the availability of any cost-sharing assistance program for any medication for which a generic drug substitute is not available. The provisions of this act shall apply to health benefit plans entered into, amended, extended, or renewed on or after August 28, 2026. This act is identical to SB 1327 (2026), SB 970 (2026), SB 840 (2026), HB 1941 (2026), HB 1681 (2026), and HB 79 (2025) and substantially similar to provisions in SCS/SB 970 (2026), HCS/HBs 1941, 2279, & 1681 (2026), SB 45 (2025), and similar to provisions in SB 187 (2025), SB 512 (2025), SB 1106 (2024), SB 844 (2024), SB 1190 (2024), HCS/HB 442 (2023), HB 1628 (2024), SB 269 (2023), and SB 1031 (2022). TAYLOR MIDDLETON

SB 846 - This act enacts provisions relating to insurance coverage of pharmacy services. CLINICIAN-ADMINISTERED DRUGS (Section 376.411) This act provides that a health carrier or pharmacy benefits manager (PBM) shall not impose any penalty, impediment, differentiation, or limitation on participating providers for providing medically necessary clinician-administered drugs, regardless of whether the participating provider obtains the drugs from an in-network provider, including but not limited to refusing to approve or pay, or reimbursing less than the contracted payment amount. Carriers and PBMs shall not impose any penalty, impediment, differentiation, or limitation on a covered person who is administered medically necessary clinician-administered drugs, regardless of whether the participating provider obtains the drugs from an in-network provider, including but not limited to: limiting coverage or benefits; requiring an additional fee, higher co-payment, or higher coinsurance amount; or interfering with a patient's ability to obtain a clinician-administered drug from the patient's provider or pharmacy of choice by any means, including but not limited to inducing, steering, or offering financial or other incentives. Carriers and PBMs shall not impose any penalty, impediment, differentiation, or limitation on any pharmacy that is dispensing medically necessary clinician-administered drugs, regardless of whether the participating provider obtains the drugs from an in-network provider, including but not limited to requiring a pharmacy to dispense the drugs to a patient with the intention that the patient will transport the medication to a health care provider for administration. These provisions shall not apply if the clinician-administered drug is not otherwise covered by the carrier or PBM. These provisions are identical to provisions in SB 13 (2025), the introduced SB 751 (2024), HCS/HB 2267 (2024), SB 26 (2023), HCS/HB 198 (2023), SB 1129 (2022), and HB 2305 (2022), and similar to provisions in SB 921 (2022), SB 1129 (2022), and HB 2305 (2022). REFERENCE PRODUCTS AND BIOSIMILARS (Section 376.415) A health carrier or PBM providing coverage for a reference product or a biological product that is biosimilar to the reference product shall provide coverage for the reference product and all biological products that have been deemed biosimilar to the reference product. The scope, extent, and amount of the required coverage shall be the same, including but not limited to any payment limitations or cost-sharing obligations. These provisions are identical to provisions in SB 13 (2025), the introduced SB 751 (2024), HCS/HB 2267 (2024), SB 26 (2023), HCS/HB 198 (2023), SB 1129 (2022), and HB 2305 (2022), and similar to provisions in SB 921 (2022), SB 1129 (2022), and HB 2305 (2022). 340B DRUG PRICING PROGRAM (Section 376.416) Under this act, no health carrier or pharmacy benefits manager (PBM) shall discriminate against a covered entity or a pharmacy, as such terms are defined in the act, by: • Reimbursing a covered entity or pharmacy for a quantity of a 340B drug, as defined in the act, in an amount less than the carrier, PBM, or affiliate would pay to any other similarly situated pharmacy for such quantity of the drug on the basis that the entity or pharmacy is a covered entity or a pharmacy, or that the entity or pharmacy dispenses 340B drugs. (Section 376.416.2(1)); • Imposing any terms or conditions on covered entities or pharmacies which differ from the terms or conditions applicable to other similarly situated pharmacies or entities on the basis that the entity or pharmacy is a covered entity or dispenses 340B drugs, including but not limited to certain terms and conditions described in the act. (Section 376.416.2(2)); • Interfering with an individual's choice to receive a 340B drug from a covered entity or pharmacy. (Section 376.416.2(3)); • Discriminating in reimbursement to a covered entity or pharmacy based on the determination or indication a drug is a 340B drug. (Section 376.416.2(4)); • Requiring a covered entity or pharmacy to identify a 340B drug sooner than 45 days after the point of sale of the drug. (Section 376.416.2(5)); • Refusing to contract with a covered entity or pharmacy for reasons other than those that apply equally to entities or pharmacies that are not covered entities or similarly situated pharmacies, or on the basis that the entity or pharmacy is a covered entity as described under federal law, or on the basis that the entity or pharmacy is described as a covered entity under provisions of federal law. (Section 376.416.2(6)); • Denying the covered entity the ability to purchase drugs at 340B program pricing by substituting a rebate discount. (Section 376.416.2(7)); • Refusing to cover drugs purchased under the 340B drug pricing program. (Section 376.416.2(8)); or • Requiring a covered entity or pharmacy to reverse, resubmit, or clarify a 340B-drug pricing claim after the initial adjudication unless these actions are in the normal course of pharmacy business and not related to the 340B drug pricing, except as required by federal law. (Section 376.416.2(9)). The Director of the Department of Commerce and Insurance shall impose a civil penalty on any health carrier or PBM violating certain provisions of the act, not to exceed $5,000 per violation per day. (Section 376.416.3). These provisions are identical to provisions in SB 13 (2025), and similar to provisions in SB 372 (2025), HB 784 (2025), HB 785 (2025), HB 943 (2025), the introduced SB 751 (2024), SCS/SBs 978 & 1035 (2024), SB 1213 (2024), HCS/HB 2267 (2024), HB 1977 (2024), SB 26 (2023), HCS/HB 198 (2023), SB 426 (2023), HB 197 (2023), SB 921 (2022), HCS/HB 1677 (2022), SB 1129 (2022), and HB 2305 (2022). PRIOR AUTHORIZATION OF HEALTH CARE SERVICES (Sections 376.2100, 376.2102, 376.2104, 376.2106, and 376.2108) This act enacts provisions relating to prior authorization of health care services. Beginning January 1, 2027, health care providers shall not be required to obtain prior authorization for a health care service unless the health carrier or utilization review entity determines that in the most recent evaluation period, as defined in the act, less than 90% of the prior authorization requests submitted by that provider for that health care service were approved or would have been approved. Also beginning January 1, 2027, health care providers shall not be required to obtain prior authorization for any health care services unless the health carrier or utilization review entity has approved or would have approved less than 90% of all prior authorization requests submitted by that provider for health care services. Health carriers or utilization review entities may elect to have certain hospitals determine which of certain conditions, laid out in the act, the hospital will comply with in order to obtain a prior authorization exemption under the act. Exemptions from prior authorization under the act shall not apply to: pharmacy services, not to exceed the amount of $100,000; imaging services, not to exceed $100,000; cosmetic procedures that are not medically necessary; or investigative or experimental treatments. Maximum dollar amounts for these exceptions shall be adjusted annually for inflation as described in the act. The act further specifies certain prior authorization requests that shall not be included in making determinations under the act, specifies identification methods for the providers, includes provisions for the auditing and retraction of determinations under the act, allows for health carriers and utilization review entities to require providers to use an online portal to submit prior authorization requests, requires adverse determinations under the act to be reviewed by a clinical peer of the provider, and requires a grace period for patients who have received prior authorization for a 90-day supply of medication. Health carriers and utilization review entities shall notify providers within 25 days after a determination is made under the act, shall include in the notification certain information used in making the determination, shall establish an appeals process for the providers, and shall maintain an online prior authorization portal as described in the act. No health carrier or utilization review entity shall deny or reduce payment to a health care provider for a health care service for which the provider has prior authorization, except as described in the act. These provisions shall not apply to MO HealthNet services not provided through a managed care organization, or to providers who have not participated in a health benefit plan offered by the health carrier for at least one full evaluation period. These provisions are identical to provisions contained in SB 841 (2026), SB 13 (2025), HCS/SS#2/SB 79 (2025), HB 618 (2025), and similar to SB 897 (2026), HCS/HB 3010 (2026), HB 1675 (2026), SB 230 (2025), SB 751 (2024), SB 983 (2024), HB 1976 (2024), HB 2267 (2024), SB 576 (2023), and HB 1045 (2023). TAYLOR MIDDLETON

SB 1327 - This act provides that when calculating an enrollee's overall contribution to an out-of-pocket max or any cost-sharing requirement under a health benefit plan, a health carrier or pharmacy benefits manager shall include any amounts paid by the enrollee or paid on behalf of the enrollee for any medication for which a generic substitute is not available. Additionally, no health carrier or pharmacy benefits manager shall design benefits in a manner that takes into account the availability of any cost-sharing assistance program for any medication for which a generic drug substitute is not available. The provisions of this act shall apply to health benefit plans entered into, amended, extended, or renewed on or after August 28, 2026. This act is identical to SB, 1448 (2026), SB 970 (2026), SB 840 (2026), HB 2279 (2026), HB 1941 (2026), HB 1681 (2026), HB 79 (2025) and substantially similar to provisions in SCS/SB 970 (2026), HCS/HB 1941, 2279, & 1681 (2026), SB 45 (2025), and similar to provisions in SB 187 (2025), SB 512 (2025), SB 1106 (2024), SB 844 (2024), SB 1190 (2024), HCS/HB 442 (2023), HB 1628 (2024), SB 269 (2023), and SB 1031 (2022). TAYLOR MIDDLETON

Modifies provisions relating to the Missouri community service commission

SB 1705 - This act requires health benefit plans issued or renewed on or after January 1, 2026, to provide coverage for certain preventative health care services without cost-sharing. Such services shall be consistent with the recommendations and guidelines of the U.S. Preventative Services Task Force, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention, and the Health Resources and Services Administration, and related federal rules or guidance issued as of December 31, 2025. The Director of the Department of Commerce and Insurance shall, by rule, adopt regulations to require health benefit plans to provide coverage for preventative health care services without cost-sharing requirements consistent with the recommendations and guidance of such entities issued after December 31, 2025. Additionally, this act establishes the "Health Insurance Preventative Health Care Services Advisory Committee" within the Department, which shall consist of 5 members, three of whom will represent health care providers and two of whom will represent health carriers and health benefit plans. The advisory committee shall meet at least once a year to consider any updates or modifications to the preventative health care services described in this act and shall submit a report of any recommendations to the Department, the General Assembly, and the Governor by November first each year. This act is identical to HB 3452 (2026), and substantially similar to HB 3450 (2026). TAYLOR MIDDLETON

SB 867 - This act requires certain financial information regarding the Missouri Empowerment Scholarship Accounts Program (MOScholars) to be posted semi-annually on the Missouri Accountability Portal. Specifically, the Portal shall include the following information: (1) The full name of each parent of a student who receives a scholarship from each educational assistance organization; (2) The total amount of money awarded to each parent's student; and (3) The total amount of money remitted from each scholarship account to each qualified school. Educational assistance organizations shall supply the required information to the State Treasurer no later than July 1 and January 1 of each year. The State Treasurer shall have 48 hours to deliver such information to the Office of Administration. OLIVIA SHANNON

SB 1107 - This act provides that no person shall receive compensation for advising or assisting, or referring to another person for such purposes, any individual with regard to any veterans benefits matter, as described in the act, unless such individual provides a written agreement containing the terms of the fees, provides certain disclosures, and complies with requirements under federal law. Additionally, no person shall advertise for such services without including a disclosure as specified in the act. Furthermore, no person shall receive compensation for any services rendered before the date on which a notice of disagreement is filed with the United States Department of Veterans Affairs and no person shall guarantee the receipt of specific veteran benefits. Any person who violates this act shall be guilty of a class A misdemeanor. This act is identical to SB 300 (2025), SB 1405 (2024), is substantially similar to HB 399 (2025), and is similar to a provision in HB 80 (2025), SB 316 (2025), HB 1102 (2025), and in HCS/HB 1490 (2024). KATIE O'BRIEN

SB 1183 - Under the act, a creator, as defined in the act, shall not, within 18 weeks of an election, distribute a synthetic media message that the creator knows or should have known is a deceptive and fraudulent deepfake, as defined in the act. These provisions shall not apply if the creator of the audio or visual media includes a certain disclosure statement, as described in the act. A candidate whose appearance, action, or speech is depicted through the use of a deceptive and fraudulent deepfake may seek injunctive or other equitable relief from the creator prohibiting the publication of such deceptive and fraudulent deepfake. A person in violation of provisions under the act may be subject to certain criminal and civil penalties, as described in the act. The act shall not apply to certain exceptions and media as described in the act. The act is similar to a provision in SCS/HCS/HBs 2628 & 2603 (2024). JULIA SHEVELEVA